Faculty Research Interests
Surgical Research has expertise, resources, facilities, and environment to conduct research in both the basic and the clinical sciences of trauma and surgical critical care, sepsis, surgical and endocrine oncology, wound healing and abdominal wall reconstruction. Research is multidisciplinary and includes investigators with specialties in surgery, medicine, physiology, pathology, biochemistry, immunology, microbiology, and molecular biology.
Principal investigators supporting major research efforts in the Department of Surgery are:
Tony Godfrey, PhD, Associate Chair, Surgical Research
Dr. Godfrey’s research is focused on cancer genetics and molecular pathology. Research projects use state-of-the-art genetic and genomic approaches to address clinical needs in the areas of cancer diagnosis, prognosis and therapy. Currently the major focus of Dr. Godfrey’s research is on Barrett’s esophagus and esophageal adenocarcinoma; a tumor with rapidly increasing incidence in the United States and other western countries. The Godfrey lab works closely with translational research teams comprised of surgeons, pathologists and oncologists in order to develop new molecular approaches to cancer detection, staging and treatment.
See a listing of Dr. Godfrey’s publications on ResearcherID, a service of the Thomson Reuters (Scientific) Inc.
Peter Burke, MD, FACS
As the Chief of Trauma Services at Boston Medical Center - a busy urban Level-I Trauma Center – and Professor of Surgery at Boston University School of Medicine, Dr. Peter Burke is involved in the daily clinical care of a diffuse population of trauma patients. His clinical practice also extends to the provision of surgical ICU care and the management of trauma and surgical patients during their time in the Surgical Intensive Care Unit (SICU). The Burke lab focuses on research exploring the molecular events surrounding the response to injury. Specifically looking at transcriptional regulatory mechanisms altered during the injury response. Burke’s clinical research interests involve developing a better understanding of the overall injury response with a special interest in the nutritional needs of trauma and ICU patients. The effects of metabolic and nutritional support on the inflammatory response and there interactions with other ongoing therapies in ICU patient’s remains an area of active and ongoing study.
Mohammad Eslami, MD
Dr. Elsami is an Attending Surgeon in the Division of Vascular and Endovascular Surgery at Boston Medical Center where he also serves as Program Director of the Vascular Surgery Fellowship and Associate Professor of Surgery and Radiology at Boston University School of Medicine. He is interested in vascular surgical outcomes and cost effectiveness using large patient databases such as National Inpatient Sample, ACS National Surgical Quality Improvement Plan and Vascular Quality Initiative . Specifically, Dr. Eslami is interested in developing biostatistical risk models predicting mortality and/or adverse outcomes after vascular procedures. The robustness of such models will help surgeons more accurately analyze an individual patient’s risk and help with patient decision-making about surgery.
Alik Farber, MD
As Division Chief of Vascular and Endovascular Surgery at Boston Medical Center and Professor of Surgery of Boston University School of Medicine Dr. Alik Farber leads a multidisciplinary clinical research unit that is based in the Division of Vascular and Endovascular Surgery. The mission of the Boston Medical Center Vascular Research Consortium is to improve the care of patients with vascular disease through innovative research. Resent research endeavors stemming from the Consortium included projects involving aortic aneurysms, venous disease, carotid disease and vascular trauma. Dr. Farber’s specific research interests include peripheral arterial disease and dialysis access. In October of 2013 he was awarded $25 million by the National Institutes of Health (NIH) to conduct a four-year, randomized clinical trial—the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia). The trial will compare traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia. BEST-CLI aims to enroll 2,100 participants and be conducted at 120 clinical centers in the United States and Canada.
Hiran Fernando, MBBS, FRCS
As Division Chief of Thoracic Surgery at Boston Medical Center and Professor of Surgery at Boston University School of Medicine, Dr. Fernando has a clinical practice that utilizes minimally invasive approaches to treat lung and esophageal diseases. His research interests are related to this and are focused in two main areas. The first is the appropriate management of high-risk patients with early stage (potentially curable) lung cancer. Treatment options for such patients include minimally invasive resection, ablative techniques and sterotactic radiation therapy. The second area of focus is with gastroesophageal disease, Barrett’s Esophagus (BE) and achalasia looking at minimally invasive surgical or endoscopic approaches for therapy.
Virginia R. Litle, MD, FACS
As an Attending Surgeon in the Division of Thoracic Surgery at Boston Medical Center and Associate Professor of Surgery at Boston University School of Medicine, Dr. Virginia Litle is involved in the daily clinical care of patients with Barrett’s Esophagus (BE), gastroesophageal disease, esophageal cancer and lung cancer. As Director of the Barrett’s Esophagus Program, Dr. Litle is actively building the Barrett’s Esophagus Outcomes databank through which patients undergoing ablation of Barrett’s esophagus and anti-reflux procedures are followed for response to treatment. She works with Dr. Tony Godfrey implementing a less invasive approach for surveying patients with Barrett’s esophagus involving a sponge for collecting precancerous cells and genetic material to improve the management of patients at risk for the deadly esophageal cancer.
Matthew Nuhn, MD
As Division Chief of Transplant Surgery at Boston Medical Center and Assistant Professor of Surgery at Boston University School of Medicine Dr. Nuhn is involved in the daily care of patients with end organ disease as well as the patient being prepared for surgery. Within the field of transplant surgery Dr. Nuhn has an interest in outcomes. There are many ways in which transplant outcomes can be assessed and recently the division of transplant surgery has looked at BK virus predominance and outcomes in the BMC immunosuppressed population. Future areas of interest are outcomes related to the undocumented transplant patient.
Beda Sarkar, MD, PhD
As an Attending Surgeon in the Section of Acute Care and Trauma Surgery and Laszlo N. Tauber Assistant Professor of Surgery at Boston University School of Medicine, Dr. Sarkar’s research examines the negative impact of alcohol on survival in sepsis using a murine model. The projects examine the acute phase response generated in the liver as well as neutrophil phagocytic function which clears the bacterial infection.